Inventors with similar research interests:
Location History:
- San Diego, CA (US) (1996 - 1998)
- La Jolla, CA (US) (1997 - 2006)
- Leucadia, CA (US) (1997 - 2011)
- Encinitas, CA (US) (2004 - 2022)
Company Filing History:
16 out of 656 
12 out of 12 
8 out of 9 
Years Active: 1996-2022
Areas of Expertise:
Title: Douglas J Jolly: Innovating Breakthroughs in Recombinant Viral Vectors
Introduction:
Douglas J Jolly, a prominent inventor based in Encinitas, CA, has remarkably contributed to the field of molecular biology and gene therapy through his extensive patent portfolio. With an impressive total of 53 patents to his name, he has demonstrated an exceptional ability to innovate in the realm of recombinant vectors, revolutionizing the treatment of various diseases and disorders. This article delves into Douglas Jolly's latest patents, career highlights, notable collaborations, and the impact he has made in the field of medical sciences.
Latest Patents:
Douglas J Jolly's latest patents showcase his cutting-edge work in the field of recombinant vectors. One of his recent inventions includes the development of modified recombinant retroviruses containing a 2A-peptide or peptide-like coding sequence linked to a heterologous polynucleotide. These modified vectors have shown promising results in the treatment of diseases and disorders. Additionally, he has also patented a retroviral vector with immune-stimulating activity, highlighting a unique approach to combating cancers.
Career Highlights:
Working with renowned companies such as Chiron Corporation and Tocagen Inc., Douglas J Jolly has played a significant role in advancing gene therapy and viral vector technology. His knack for innovation and expertise in molecular biology has led to exponential growth in the development of recombinant viral vectors for therapeutic purposes.
Collaborations:
Throughout his career, Douglas J Jolly has had the opportunity to collaborate with esteemed colleagues, further amplifying his impact in the field. Notable amongst his collaborators are Harry E Gruber and James G Respess. Such collaborations have allowed for the exchange of ideas, cross-pollination of knowledge, and ultimately, the realization of groundbreaking medical advancements.
Conclusion:
Douglas J Jolly's contributions to the field of recombinant viral vectors stand as a testament to his ingenuity and dedication to scientific advancements. His extensive patent portfolio, along with his collaborations with industry leaders, has propelled the field of gene therapy forward. As he continues to innovate, Douglas Jolly is likely to bring forth further breakthroughs in the treatment of diseases and disorders, leaving a lasting impact on the medical community and the lives of countless individuals.
(Note: The information presented in this article is based on the given data and may not reflect the current status or developments of Douglas J Jolly's career. For the most accurate and updated information, please refer to reputable sources or consult the official website of Douglas J Jolly or the respective companies mentioned.)